CHM and familial pancreatic carcinoma: Since pancreatic cancer cells maintain intracellular levels of nutrients via pathways of both autophagy and macropinocytosis, REP1-mediated autophagy regulation could be a potential therapeutic target for treating pancreatic cancer.